REGN vs TMP
Regeneron Pharmaceuticals Inc (REGN) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the REGN and TMP stock pages for the full models.
Not investment advice.